Utilizing personalized tumor-specific methylation haplotypes of circulating tumor DNA for monitoring minimal residual disease in hepatocellular carcinoma patients after curative resection

被引：1
|
作者：
Yang, X. [1 ]
Guo, D. [1 ]
Zhang, S-Y. [1 ]
Xu, M-J. [2 ]
Chen, H. [2 ]
Ma, C. [2 ]
Su, M-Y. [2 ]
He, Q. [2 ]
Zhang, Y. [2 ]
Su, Z. [2 ]
Liu, R. [2 ]
Fan, J. [1 ]
Zhou, J. [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp Affiliated, Dept Liver Surg & Transplantat, Shanghai, Peoples R China
[2] Singlera Genom Inc, R&D, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
958P
引用
收藏
页码：S661 / S662
页数：2
相关论文
共 50 条
  • [41] Utility of circulating tumor DNA (ctDNA) for detection of minimal residual disease (MRD) after curative-intent therapy in localized pancreatic cancer (PDAC)
    Yanala, Ujwal R.
    Martos, Mary
    Dickey, Erin M.
    Corona, Andres
    Ezenwajiaku, Nkiruka
    Pizzolato, Joseph
    Terrero, Gretel
    Hester, Caitlin A.
    Merchant, Nipun
    Hosein, Peter
    Datta, Jash
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S23 - S24
  • [42] Circulating tumor DNA as a marker of Minimal Residual Disease in squamous cell carcinoma of the head and neck: an agnostic approach
    Honore, N.
    Galot, R.
    van Marcke, C.
    Helaers, R.
    Mendola, A.
    Limaye, N.
    Machiels, J-P.
    ORAL ONCOLOGY, 2021, 118
  • [43] Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma
    Liu, Tao
    Yao, Qianqian
    Jin, Hai
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [44] A Moral Score Utilizing Serum Tumor Markers Provides Refined Prognostication of Patients with Hepatocellular Carcinoma after Curative Resection: Data from 662 Consecutive Patients
    Lee, Hyo Young
    Lee, Yun Bin
    Lee, Jeong-Hoon
    Chung, Sung Won
    Kim, Minseok Albert
    Kim, Sun Woong
    Yoon, Jun Sik
    Chang, Young
    Cho, Eun Ju
    Yu, Su Jong
    Kim, Yoon Jun
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    Yoon, Jung-Hwan, Sr.
    HEPATOLOGY, 2018, 68 : 530A - 530A
  • [45] WHOLE-GENOME SEQUENCING YIELDS TUMOR-SPECIFIC DNA REARRANGEMENTS AS TARGETS FOR MINIMAL RESIDUAL DISEASE DETECTION IN NEUROBLASTOMA
    van Wezel, Esther M.
    Zappeij-Kannegieter, Lily
    Zwijnenburg, Danny A.
    Koster, Jan
    Molenaar, Jan J.
    Versteeg, Rogier
    Caron, Huib N.
    van der Schoot, C. Ellen
    Tytgat, Godelieve A.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1013 - 1013
  • [46] Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment
    Simon, N.
    Chae, Y. K.
    Mohindra, N.
    Villaflor, V.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S623 - S624
  • [47] Comparing baseline VAF in circulating tumor DNA and tumor tissues predicting prognosis of patients with colorectal cancer liver metastases after curative resection
    Jin, Ke-min
    Bao, Quan
    Zhao, Ting-ting
    Wang, Hong-wei
    Huang, Long-fei
    Wang, Kun
    Xing, Bao-cai
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (09)
  • [48] Personalized circulating tumor DNA (ctDNA) analysis in predicting residual disease after neoadjuvant chemoradiotherapy (nCRT) for esophageal squamous cell carcinoma (ESCC)
    Liu, Zhichao
    Yang, Yang
    Liu, Jun
    Zhang, Hong
    Yu, Hong
    Han, Yuchen
    Fu, Xiao-Long
    Zhang, Hao
    Xiang, Jianxing
    Chen, Songan
    Li, Xi
    Zhu, Mingjun
    Li, Zhigang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] HBV VIRUS-HOST CHIMERA DNA SERVES AS A PERSONALIZED CIRCULATING BIOMARKER FOR RESIDUAL TUMORS AFTER SURGICAL RESECTION OF HEPATOCELLULAR CARCINOMA
    Chau, Gar-Yang
    Lee, Wei-Chen
    Ho, Ming-Chih
    Chen, Teng-Wei
    Hu, Rey-Heng
    Wu, Tsung-Han
    Lei, Hao-Jan
    Chou, Shu-Cheng
    Fan, Hsiu-Lung
    Wu, Ting-Jung
    Ho, Cheng-Maw
    Chou, Hong-Shiue
    Tzeng, Sheng-Tai
    Wang, Ya-Chun
    Yeh, Shiou-Hwei
    Chen, Pei-Jer
    HEPATOLOGY, 2023, 78 : S198 - S198
  • [50] Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection
    Yamamura, Kazuo
    Sugimoto, Hiroyuki
    Kanda, Mitsuro
    Yamada, Suguru
    Nomoto, Shuji
    Nakayama, Goro
    Fujii, Tsutomu
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2014, 21 (09) : 682 - 688
12345